Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ravaud

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
Clinical Genitourinary Cancer|May 22, 2019
Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the LiteratureManon de Vries-Brilland, Baptiste Sionneau, Caroline Dutriaux, et al.
Urologic Oncology|March 11, 2009
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancersHervé Wallerand, Grégoire Robert, Gilles Pasticier, et al.
BJU International|October 15, 2010
Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trialSergio Bracarda, Joaquim Bellmunt, Bohuslav Melichar, et al.
Clinical Interventions in Aging|April 30, 2013
Optimal management of renal cell carcinoma in the elderly: a reviewAmandine Quivy, Amaury Daste, Asma Harbaoui, et al.
Cancer Treatment Reviews|April 27, 2021
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectivesMathieu Larroquette, Florent Peyraud, Charlotte Domblides, et al.
European Urology|May 20, 2008
Update on the medical treatment of metastatic renal cell carcinomaAlain Ravaud, Hervé Wallerand, Stéphane Culine, et al.
Expert Opinion on Drug Safety|June 11, 2020
Safety of sunitinib in patients with renal cell carcinoma following nephrectomyLuc Heraudet, Charlotte Domblides, Amaury Daste, et al.
Expert Opinion on Drug Safety|February 13, 2014
Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanismsIgnacio Duran, Peter-Jürgen Goebell, Konstantinos Papazisis, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Treatment of spinal metastases in renal cell carcinoma: A critical reviewDiego Teyssonneau, Marine Gross-Goupil, Charlotte Domblides, et al.
Cardiovascular and Interventional Radiology|December 4, 2010
Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-upJean Palussière, Benjamin Marcet, Edouard Descat, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Clinical Genitourinary Cancer|May 22, 2019
Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the LiteratureManon de Vries-Brilland, Baptiste Sionneau, Caroline Dutriaux, et al.
Urologic Oncology|March 11, 2009
The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancersHervé Wallerand, Grégoire Robert, Gilles Pasticier, et al.
BJU International|October 15, 2010
Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trialSergio Bracarda, Joaquim Bellmunt, Bohuslav Melichar, et al.
Clinical Interventions in Aging|April 30, 2013
Optimal management of renal cell carcinoma in the elderly: a reviewAmandine Quivy, Amaury Daste, Asma Harbaoui, et al.
Cancer Treatment Reviews|April 27, 2021
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectivesMathieu Larroquette, Florent Peyraud, Charlotte Domblides, et al.
European Urology|May 20, 2008
Update on the medical treatment of metastatic renal cell carcinomaAlain Ravaud, Hervé Wallerand, Stéphane Culine, et al.
Expert Opinion on Drug Safety|June 11, 2020
Safety of sunitinib in patients with renal cell carcinoma following nephrectomyLuc Heraudet, Charlotte Domblides, Amaury Daste, et al.
Expert Opinion on Drug Safety|February 13, 2014
Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanismsIgnacio Duran, Peter-Jürgen Goebell, Konstantinos Papazisis, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Treatment of spinal metastases in renal cell carcinoma: A critical reviewDiego Teyssonneau, Marine Gross-Goupil, Charlotte Domblides, et al.
Cardiovascular and Interventional Radiology|December 4, 2010
Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-upJean Palussière, Benjamin Marcet, Edouard Descat, et al.
Pageof 23